-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Leaders from the Shijiazhuang Investment Promotion Bureau visited Shijiazhuang Sihua Pharmaceutical for a research visit.
Category:
Time：2021-02-16
On the fourth day of the first lunar month, Shijiazhuang Siyao Group kicked off its “cultivation” for the Year of the Ox. Early in the morning, Zhao Yong, Party Secretary and Director of the Shijiazhuang Municipal Investment Promotion Bureau, accompanied by Shang Erfei, a member of the Party Working Committee and Deputy Director of the Management Committee of the Shijiazhuang High-tech Zone, visited Shijiazhuang Siyao Group. There, Zhao extended New Year greetings to the company’s employees who had been working during the holiday period and took a close look at the factory premises to gain a thorough understanding of the company’s progress in resuming and reaching full production capacity.
Zhao Yong and his delegation listened carefully to a report on how Shijiazhuang No.4 Pharmaceutical Group has overcome numerous challenges since the outbreak of the pandemic and made every effort to ensure the production of anti-epidemic supplies. Zhao Yong stated that the vast majority of employees at No.4 Pharmaceutical Group have demonstrated the spirit of “stepping forward in critical moments and going all out in times of crisis,” making outstanding contributions to winning the battle against the epidemic. On behalf of the Municipal Investment Promotion Bureau, he expressed gratitude for the employees’ hard work and dedication since the onset of the pandemic. He also noted that the municipal Party committee and government attach great importance to the operational status of industrial enterprises during the pandemic, and the relevant functional departments will do their utmost to assist these enterprises in addressing the practical challenges they face.
During the pandemic, the Shijiazhuang Investment Promotion Bureau promptly understood the needs and concerns of industrial enterprises and did everything possible to help Shijiazhuang Sihua Pharmaceutical Group coordinate and resolve difficulties such as the shortage of product packaging boxes, thereby effectively supporting the company in fulfilling its epidemic prevention and supply-ensuring tasks.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code